PEURegen Inc., an early stage regenerative medicine company, seeks to advance the wound healing market by developing a pipeline of cost effective, synthetic, biodegradable wound care products that will result in regeneration of healthy tissue. The ability to provide a one-time application with advanced wound healing potential would reduce treatment costs dramatically, improving both patient health and quality of life.